Origio
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Origio - overview
Location
-, -, Denmark
Primary Industry
Consumer Services
About
Origio is a global provider specializing in advanced reproductive technologies and solutions for women's health, focusing on innovation to enhance fertility and gynecological care. Origio operates in the women's health sector, providing cutting-edge reproductive technologies and solutions. The company is headquartered in Denmark and has undergone various strategic initiatives to strengthen its market position. Terry Fortino serves as the CEO, bringing extensive experience in the healthcare industry.
The company has successfully raised funding through multiple rounds, including specific amounts but without disclosing exact round names or additional funding details. Origio offers a broad spectrum of medical devices and services aimed at enhancing women's reproductive health. Their product range includes advanced reproductive care technologies, assisted reproductive technology (ART) equipment, gynecological surgical instruments, and diagnostic tools, all designed to optimize clinical effectiveness. Origio serves healthcare providers, including hospitals and fertility clinics, across North America, Europe, and select markets in Asia and Australia, leveraging its nearly 35 years of industry expertise.
In the most recent fiscal year 2024, Origio reported revenues of USD 125. 91 mn with an EBITDA of USD 4. 51 mn. The company generates revenue through direct sales to healthcare providers and partnerships with fertility clinics, focusing on the sale of proprietary medical devices and training services, aligned with market standards.
Origio is focused on enhancing its product line with upcoming innovations in reproductive technology aimed at improving clinical outcomes. The company plans to enter new markets in Asia and Australia by the end of 2025. Recent funding will be strategically directed towards research and development initiatives to support these new product launches and market expansions.
Primary Industry
Consumer Services
Sub Industries
Consumer Products, Consumer Services
Website
www.origio.com
Total Amount Raised
Subscriber access only
Origio - timeline of key events
Origio - employee data
Origio - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board member | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.